MSB 7.69% $1.19 mesoblast limited

Ryoncil: ODAC/FDA Meeting Discussion, page-1717

  1. 866 Posts.
    lightbulb Created with Sketch. 196
    Whilst its true this isnt FDA approval yet as others have stated

    there is study published which indicated for the study period examined that on 100% of occasion where the ODAC recommended approval the FDA granted approval

    so its looking good

    https://jamanetwork.com/journals/jamaoncology/fullarticle/2497879
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.